Conclusions
! The effect of MMT on VL suppression differed in relation to distinct patterns of cocaine use:
• While enrollment in a MMT program was associated with increased odds of VL suppression among <daily cocaine injectors, this beneficial effect of MMT was lost among more frequent cocaine injectors.
• MMT was associated with increased odds of viral suppression among opioid users regardless of crack-cocaine use.
! Findings from this study support global calls to expand access to low-threshold Opioid Agonist Therapy to improve addiction and HIV outcomes among HIV-positive opioid users.
! Our findings also underscore the urgent need to identify novel and effective pharmacotherapies for the treatment of cocaine use disorders, as well as structural interventions to support engagement in HIV care for this population.
Results
! 397 HIV-positive opioid-users were included. • ≥daily cocaine injection in the last 6 months: 37 (9%)
• ≥daily crack-cocaine smoking in the last 6 months: 158 (40%)
! Results of the adjusted GLMM analyses of the effect of MMT on VL suppression across strata of cocaine injection and crackcocaine use are presented in Table 1 and 2, respectively. ! Measures and analyses. Using a procedure recommended by Knol and VanderWeele, 1 we used generalized linear mixed-effects (GLMM) to model the independent effect of MMT on VL suppression (< 50 copies/mL plasma) across strata of frequency (≥daily versus <daily) of cocaine injection (Model 1) and crack cocaine smoking (Model 2), after adjustment for potential confounders.
Methods
• Confounders considered included: age, ethnicity, unstable housing, incarceration, sex work, ≥daily heroin injection, ≥daily crack smoke (for Model 1). 
